FineMark National Bank & Trust Takes $255,000 Position in Axon Enterprise, Inc. (NASDAQ:AXON)

FineMark National Bank & Trust acquired a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, HoldingsChannel reports. The fund acquired 429 shares of the biotechnology company’s stock, valued at approximately $255,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of AXON. New Wave Wealth Advisors LLC bought a new stake in Axon Enterprise in the 4th quarter valued at $40,000. Y.D. More Investments Ltd acquired a new position in shares of Axon Enterprise during the fourth quarter valued at about $45,000. Prestige Wealth Management Group LLC lifted its stake in shares of Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after buying an additional 44 shares during the period. Stonebridge Financial Group LLC acquired a new stake in Axon Enterprise during the fourth quarter worth about $53,000. Finally, GPS Wealth Strategies Group LLC increased its stake in Axon Enterprise by 74.1% during the fourth quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company’s stock valued at $56,000 after acquiring an additional 40 shares during the period. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares in the company, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Jeri Williams sold 307 shares of the business’s stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now directly owns 1,627 shares in the company, valued at approximately $899,275.44. This trade represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. The Goldman Sachs Group upped their target price on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. Northcoast Research downgraded shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. Robert W. Baird upped their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Barclays restated a “hold” rating on shares of Axon Enterprise in a research note on Monday, March 10th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $600.00 price objective on shares of Axon Enterprise in a research note on Wednesday, February 26th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $604.67.

Axon Enterprise Stock Down 3.1 %

NASDAQ:AXON opened at $559.06 on Thursday. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99. The firm has a market capitalization of $42.84 billion, a price-to-earnings ratio of 144.46, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The stock’s 50 day moving average price is $591.51 and its two-hundred day moving average price is $546.76.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.